1FME:BIT
Fresenius Medical Care AG
€39.52
arrow_upward
+0.79%(+0.31) 1D
Apr 23, 10:51:14 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1FME...
Mkt. cap
11.35B
Avg. vol.
165.00
Volume
0.00
Dividend
3.77%
Quarterly dividend
€0.37
Ex dividend date
May 22, 2026
P/E ratio
11.76
52-wk high
€53.74
52-wk low
€35.67
EPS
€3.36
No. of employees
110K
News stories
From sources across the web
Investing.com
·
3 hours ago
Humacyte regains ex-U.S. rights to Symvess from Fresenius
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees110K
Founded1996
Headquarters-
SectorHealth care provider
Websitefreseniusmedicalcare.com
AI content may include mistakes. Learn more